GlobeNewswire Inc | Nov 9, 2020 07:00AM EST

November 09, 2020

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc.(Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 16th, 2020 at 4:30pm Eastern Time to discuss corporate updates and financial results for the third quarter ended September 30, 2020.

The call can be accessed by dialing (844) 296-7720 (U.S. andCanada) or (574) 990-1148 (international) and entering passcode 1776248.

To access the live audio webcast, or the subsequent archived recording, visit the Investors and Media Calendar of Events section of the Sunesis website atwww.sunesis.com. The webcast will be recorded and available for replay on the companys website for two weeks.

AboutSunesis Pharmaceuticals

Sunesis is a biopharmaceutical company developing novel targeted inhibitors for the treatment of hematologic and solid cancers. Sunesis has built an experienced drug development organization committed to improving the lives of people with cancer. The Company is focused on advancing its novel kinase inhibitor pipeline, including first-in-class PDK1 inhibitor SNS-510. SNS-510 is in IND-enabling studies and vecabrutinib has completed a Phase 1b trial in patients with advanced B cell malignancies.

For additional information on Sunesis, please visitwww.sunesis.com.

SUNESIS and the logos are trademarks ofSunesis Pharmaceuticals, Inc.

Investor and Media Inquiries: Par HyareMaeve Conneighton Sunesis Pharmaceuticals Inc.Argot Partners 650-266-3784212-600-1902